Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ANGEL ACQUISITION CORP.Financial_Report.xls
EX-31 - EXHIBIT 31 - ANGEL ACQUISITION CORP.exhibit31.htm
EX-32 - EXHIBIT 32 - ANGEL ACQUISITION CORP.exhibit32.htm



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 Washington, DC 20549

 

Form 10-Q

(MARK ONE)

 

x

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2011

 

OR

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

 

For the transition period from  ______________ to ______________

 

 

Commission File Number: 000-32829


BIOGERON, INC.

(Exact name of registrant as specified in its charter)


Nevada

88-0470235

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

 

1802 N. Carson Street, Suite 212-3018

Carson City, Nevada


89701

(Address of Principal executive offices)

(Zip Code)

 

 

 

 

Registrant’s telephone number, including area code.

(775) 887-0670


 Angel Acquisition Corp.
(Former name, if changed since last report)

 

 

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes x    No o


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405) during the precedent 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes o      No o

 






Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. 



Large accelerated filer             

o

Accelerated filer                         

o

Non-accelerated filer                 

o

Smaller reporting company   

x


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o    No x

 

State the number of shares outstanding of each of the issuer's classes of common equity, as of the latest practicable date: As of November 14, 2011, the issuer had 7,905,908,229 shares of its common stock issued and outstanding.

 

 


 



2






 


Table of Contents


    

 

 

Page

PART I  FINANCIAL INFORMATION

 

 

 

 

Item 1

Financial Statements

4

Item 2  

Management’s Discussion and Analysis or Plan of Operation

20

Item 3

Quantitative and Qualitative Disclosures About Market Risk

26

Item 4

Controls and Procedures

28

 

 

 

PART II   OTHER INFORMATION

 

 

 

 

Item 1

Legal Proceedings

28

Item 1A

Risk Factors

28

Item 2

Unregistered Sales of Equity Securities and Use of Proceeds

28

Item 3

Defaults Upon Senior Securities

29

Item 4

[Reserved and Removed]

29

Item 5

Other Information

29

Item 6

Exhibits

29

 

 

 

Signatures

30

 

 

 




3






 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

The accompanying unaudited interim consolidated financial statements of BioGeron, Inc. fka Angel Acquisition Corp. ("BioGeron") have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission ("SEC"), and should be read in conjunction with the audited financial statements and notes thereto contained in Angel’s Annual Report filed with the SEC on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.

 










4







BIOGERON, INC.

(F/K/A ANGEL ACQUISITION CORP.)

BALANCE SHEETS

 

 

 

 

 

 

 

 

September 30,

 

 

December 31,

 

2011

2010

ASSETS

(unaudited)

 

Current assets

 

 

 

 

 

     Cash

$

567

 

$

8,151

     Loan receivable

 

63,372

 

 

54,950

     Accounts receivable

 

450

 

 

450

     Prepaid

 

-

 

 

1,000

     Other receivables

 

-

 

 

1,473

         Total current assets

 

64,389

 

 

66,024

 

 

 

 

 

 

Property, plant and equipment, net (note 6)

 

                      -

 

 

1,228,831

Property held for resale (note 7)

 

-

 

 

496,000

Total assets

$

64,389

 

$

1,790,855

 

 

 

 

 

 

LIABILITES AND STOCKHOLDERS' EQUITY (DEFICIT)

 

 

 

Current liabilities

 

 

 

 

 

    Accounts payable

$

24,959

 

$

6,929

    Notes payable

 

161,761

 

 

1,979,136

   Note payable, net of discount

 

33,288

 

 

-

    Accrued expenses

 

6,463

 

 

2,019

    Accrued salary

 

-

 

 

60,000

    Derivative liability

 

100,181

 

 

-

    Other liabilities (note 5)

 

51,960

 

 

103,670

          Total current liabilities

 

378,612

 

 

2,151,754

Loan payable, long term

 

50,000

 

 

-

Total liabilities

 

428,612

 

 

2,151,754

 

 

 

 

 

 

Stockholders' equity (deficit)

 

 

 

 

 

Series A preferred stock, $.00001 par value, 10,000,000 shares authorized, 9,976,591 and 4,335,000 shares issued and outstanding, respectively

 

100

 

 

43

Series B preferred stock $.00001 par value, 50,000,000 shares authorized 30,000,000 and 30,000,000 shares issued and outstanding, respectively

 

300

 

 

300



5









Series C preferred stock, $.00001 par value, 30,000,000  shares authorized, no shares issued and outstanding

 

-

 

 

-

Common stock, 15,900,000,000 shares authorized, par value $.00001, 7,905,908,229 and 7,755,908,229 shares issued and outstanding, respectively

 

79,059

 

 

76,559

Common stock subscribed

 

85,000

 

 

105,723

Series A preferred stock subscribed

 

-

 

 

30,000

     Additional paid-in capital

 

20,466,442

 

 

19,834,425

     Accumulated deficit

 

(20,995,124)

 

 

(20,407,949)

          Total stockholders' equity (deficit)

 

(364,223)

 

 

(360,899)

          Total liabilities and stockholders' equity (deficit)

$

64,389

 

$

1,790,855

 

 

 

 

 

 




The accompanying notes are an integral part of these financial statements.



 



6







 

BIOGERON, INC.

 

(F/K/A ANGEL ACQUISITION CORP.)

 

STATEMENTS OF OPERATIONS

 

 (UNAUDITED)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Nine Months Ended

 

 

For the Three Months Ended

 

September 30,

 

September 30,

 

 

 

2011

 

 

2010

 

 

2011

 

 

2010

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

Real estate revenue

$

26,355

 

$

100,284

 

$

2,000

 

$

23,976

 

Cost of sales

 

20,084

 

 

49,701

 

 

-

 

 

7,980

 

   Gross margin

 

6,271

 

 

50,583

 

 

2,000

 

 

15,996

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

92,834

 

 

107,815

 

 

27,595

 

 

34,013

 

Officer compensation

 

12,650

 

 

-

 

 

12,650

 

 

-

 

Consulting, legal and Professional

 

37,359

 

 

79,250

 

 

5,981

 

 

9,222

 

   Total operating expenses

 

142,843

 

 

187,065

 

 

46,226

 

 

43,235

 

Loss from operations

 

(136,572)

 

 

(136,482)

 

 

(44,226)

 

 

(27,239)

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(28,809)

 

 

(180,333)

 

 

(12,469)

 

 

(22,740)

 

Loss on derivative liability

 

(100,181)

 

 

-

 

 

(100,181)

 

 

-

 

Loss on disposal of fixed assets

 

(331,413)

 

 

-

 

 

-

 

 

-

 

Forgiveness of Debt

 

9,800

 

 

1,579,394

 

 

-

 

 

-

 

   Total other income (expense)

 

(450,603)

 

 

1,399,061

 

 

(112,650)

 

 

(22,740)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

$

(587,175)

 

$

1,262,579

 

$

(156,876)

 

$

(49,979)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share

$

(0.00)

 

$

(0.00)

 

$

(0.00)

 

$

(0.00)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average number of common shares

 

7,862,867,936

 

 

6,087,905,486

 

 

7,905,908,229

 

 

7,755,900,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.






7







BIOGERON, INC.

(F/K/A ANGEL ACQUISITION CORP.)

STATEMENTS OF CASH FLOWS

 (UNAUDITED) 

 

 

 

 

 

 

 

 

 

 

For the Nine Months Ended

 

 

 

September 30,

 

 

 

2011

 

 

2010

Cash flows from operating activities

 

 

 

 

 

Net  income (loss)

$

(587,175)

 

$

1,262,579

Adjustments to reconcile net cash used in operating activities:

 

 

 

 

 

 

Forgiveness of Debt

 

(9,800)

 

 

(1,579,394)

 

Interest expense on note discount

 

3,288

 

 

-

 

Loss on disposal of fixed assets

 

331,413

 

 

 

 

Depreciation

 

-

 

 

19,190

 

Common stock issued for services

 

-

 

 

133,172

 

Accrued derivative liability

 

100,181

 

 

(280,293)

Changes in operating assets and liabilities:

 

 

 

 

 

 

(Increase) / Decrease in prepaids

 

2,473

 

 

(23,599)

 

(Increase ) in loan receivable

 

(8,422)

 

 

-

 

Increase in accounts payable and accrued expenses

 

41,395

 

 

44,176

Net cash (used) by operating activities

 

(126,647)

 

 

(424,169)

 

 

 

 

 

 

 

Cash flows from investing activities

 

-

 

 

-

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

Proceeds from sale of preferred stock

 

30,000

 

 

-

 

Proceeds from sale of common stock

 

3,850

 

 

-

 

Proceeds from note payable

 

136,923

 

 

270,804

 

Advances from related parties

 

6,540

 

 

161,450

 

Repayment of related party loans

 

(58,250)

 

 

(20,900)

Net cash provided by financing activities

 

119,063

 

 

411,354

 

 

 

 

 

 

 

Net decrease in cash

 

(7,584)

 

 

(12,815)

Cash – beginning of period

 

8,151

 

 

13,144

Cash – end of period

$

567

 

$

329

 

 

 

 

 

 

 

 

Supplemental Disclosures regarding cash flows:

 

 

 

 

-

 

Interest Paid

$

7,682

 

$

-

 

 

 

 

 

 

 



8








 

Non-cash financing activities:

 

 

 

 

 

 

Decrease in note payable due to foreclosure

$

897,418

 

$

-

 

Common stock issued to satisfy liabilities

$

5,000

 

$

-

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.





9






BIOGERON, INC.

(F/K/A ANGEL ACQUISTION CORP.)

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2011

(UNAUDITED)

 

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS

BioGeron, Inc. (the “Company”) a Nevada corporation, was incorporated on March 10, 1999. The Company was formerly Palomar Enterprises, Inc. On February 5, 2008, the Company changed its name to Angel Acquisition Corp. to properly reflect the change in business direction.


During the quarter ended September 30, 2010, the Company formed a wholly owned subsidiary, BioGeron, Inc. BioGeron is a privately  held  early  stage  bio-nutritional  supplement  designer,  manufacturer,  wholesaler  and  retailer.  It is a part of the Neutraceutica Industry.


On August 1, 2011, the Company filed Articles of Merger with the Secretary of State of Nevada in order to effectuate a merger whereby the Company (as Angel Acquisition Corp.) merged with its wholly-owned subsidiary, BioGeron, Inc., as a parent/ subsidiary merger with the Company as the surviving corporation. This merger, which became effective as of August 1, 2011, was completed pursuant to NRS 92A.180. Shareholder approval to this merger was not required under NRS 92A.180.  In process of the merger, the Company's name has been changed to "BioGeron, Inc." and the Company's Articles of Incorporation have been amended to reflect this name change.


NOTE 2 - PREPARATION OF FINANCIAL STATEMENTS

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Management further acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud. The Company's system of internal accounting control is designed to assure, among other items, that 1) recorded transactions are valid; 2) valid transactions are recorded; and 3) transactions are recorded in the proper period in a timely manner to produce financial statements which present fairly the financial condition, results of operations and cash flows of the Company for the respective periods being presented.


The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission for interim financial information.  Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. It is management's opinion, however, that all material adjustments (consisting of normal recurring adjustments) have been made which are necessary for a fair financial statement presentation. The results for the interim period are not necessarily indicative of the results to be expected for the full year.


The unaudited interim financial statements should be read in conjunction with the Company’s annual report on Form 10-K, which contains the audited financial statements and notes thereto, together with the Management’s Discussion and Analysis, for the fiscal year ended December 31, 2010.  The interim results for the nine months ended September 30, 2011 are not necessarily indicative of the results for the full fiscal year.



10






NOTE 3 - GOING CONCERN UNCERTAINTY

The Company has been unable to generate sufficient operating revenues and has incurred operating losses.

There is no assurance that the Company will be able to obtain additional funding through the sales of additional securities or, that such funding, if available, will be obtained on terms favorable to or affordable by the Company. It is the intent of management and controlling shareholders to provide sufficient working capital necessary to support and preserve the integrity of the corporate entity. However, there is no legal obligation for either management and/or controlling shareholders to provide such additional funding.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The financial statements do not include any adjustments that might result from this uncertainty.

NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Cash and cash equivalents

The Company considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit and other highly- liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents.


Property and Equipment


Property and equipment are stated at cost. Expenditures that increase the useful lives or capacities of the property and equipment are capitalized. Expenditures for repairs and maintenance are charged to income as incurred. Depreciation is provided using the straight-line method over the estimated useful lives as follows:


Computer equipment

3 years

Furniture and fixtures

5 years

Machinery and equipment

5 years

Building

40 years

Research and development expenses

Research and development expenses are charged to operations as incurred. There were no research and development costs incurred in the periods.


Revenue recognition


Prior to August 1, 2011 the Company generated revenue from the sale of real estate, brokerage commissions, rental properties and mortgage loan originations. Revenues from real estate sales and commissions are recognized on execution of the sales contract. The Company recorded gross commissions on the sales of properties closed. The Company paid the broker of record five percent of all transactions and 100 percent of personal sales. This is in accordance with standard procedures. The Company compensated its independent agents on a sliding scale between 70 and 80 percent based on productivity.  Revenue is recognized at "closing".




11






Income Taxes


The Company accounts for income taxes in accordance with ASC Topic 740, “Income Taxes.” ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.


Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The evaluation of a tax position is a two-step process. The first step is to determine whether it is more-likely-than-not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefits to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. Penalties and interest incurred, related to underpayment of income tax, are classified as income tax expense in the year incurred.  No significant penalties or interest relating to income taxes have been incurred during the quarter ended September 30, 2011 or the year ended December 31, 2010. GAAP also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosures, and transition.


 Earnings (loss) per share


Basic earnings (loss) per share are computed by dividing the net income (loss) by the weighted-average number of shares of common stock and common stock equivalents. Common stock equivalents represent the dilutive effect of the assumed conversion of the outstanding preferred stock.

Use of Estimates


The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the accounting period. Actual results could differ from those estimates.


Reclassification


Certain  reclassifications  have been made to the previous  financial  information  to  conform  to  the presentation  used  in the  (unaudited)  September 30, 2011  financial information.


Fair Value of Financial Instruments

The carrying amount of cash, notes receivable, accounts payable, accrued liabilities and notes payable, as applicable, approximates fair value due to the short-term nature of these items. The fair value of the related party notes payable cannot be determined because of the Company's affiliation with the parties with whom the agreements exist. The use of different assumptions or methodologies may have a material effect on the estimates of fair values.



12





ASC Topic 820, “Fair Value Measurements and Disclosures,” requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, “Financial Instruments,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures.  The carrying amounts reported in the balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:


·

Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.


·

Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.


·

Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

The Company analyzes all financial instruments with features of both liabilities and equity under ASC 480, “Distinguishing Liabilities from Equity,” and ASC 815.


The following presents the gross value of assets and liabilities that were measured and recognized at fair value.


·

Level 1: none

·

Level 2: none

·

Level 3: Derivative Liability - $100,181


RECENT ACCOUNTING PRONOUNCEMENTS


In December 2010, the FASB Accounting Standards Update 2010-29 Business Combinations Topic 805, which requires a public entity to disclose pro forma information for business combinations that occurred in the current reporting period. The disclosures include pro forma revenue and earnings of the combined entity for the current reporting period as though the acquisition date for all business combinations that occurred during the year had been as of the beginning of the annual reporting period. If comparative financial statements are presented, the pro forma revenue and earnings of the combined entity for the comparable prior reporting period should be reported as though the acquisition date for all business combinations that occurred during the current year had been as of the beginning of the comparable prior annual reporting period. Effective for business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2010. The adoption did not have an impact on the Company’s financial position and results of operations.

In March 2010, the FASB (Financial Accounting Standards Board) issued Accounting Standards Update 2010-11 (ASU 2010-11), “Derivatives and Hedging (Topic 815): Scope Exception Related to Embedded Credit Derivatives.”  The amendments in this Update are effective for each reporting entity at the beginning of its first fiscal quarter beginning after June 15, 2010.  Early adoption is permitted at the beginning of each entity’s first fiscal quarter beginning after issuance of this Update.  The Company does not expect the provisions of ASU 2010-11 to have a material effect on the financial position, results of operations or cash flows of the Company.



13




 

In February 2010, the FASB Accounting Standards Update 2010-10 (ASU 2010-10), “Consolidation (Topic 810): Amendments for Certain Investment Funds.”  The amendments in this Update are effective as of the beginning of a reporting entity’s first annual period that begins after November 15, 2009 and for interim periods within that first reporting period. Early application is not permitted.  The Company does not expect the adoption of ASU 2010-10 to have a material impact on its results of operations or financial position

In February 2010, FASB issued ASU 2010-9 Subsequent Events (Topic 855) Amendments to Certain Recognition and Disclosure Requirements ("ASU 2010-9"). ASU 2010-9 amends disclosure requirements within Subtopic 855-10. An entity that is an SEC filer is not required to disclose the date through which subsequent events have been evaluated. This change alleviates potential conflicts between Subtopic 855-10 and the SEC's requirements. ASU 2010-9 is effective for interim and annual periods ending after June 15, 2010. The Company does not expect the adoption of ASU 2010-09 to have a material impact on its results of operations or financial position.

In January 2010, FASB issued ASU 2010-6 Improving Disclosures about Fair Measurements ("ASU 2010-6"). ASU 2010-6 provides amendments to subtopic 820-10 that require separate disclosure of significant transfers in and out of Level 1 and Level 2 fair value measurements and the presentation of separate information regarding purchases, sales, issuances and settlements for Level 3 fair value measurements. Additionally, ASU 2010-6 provides amendments to subtopic 820-10 that clarify existing disclosures about the level of disaggregation and inputs and valuation techniques. ASU 2010-6 is effective for financial statements issued for interim and annual periods ending after December 15, 2010. The Company does not expect the adoption of ASU 2010-06 to have a material impact on its results of operations or financial position.

In January 2010, FASB issued ASU 2010-2 Accounting and Reporting for Decreases in Ownership of a Subsidiary- a Scope Clarification ("ASU 2010-2"). ASU 2010-2 addresses implementation issues related to the changes in ownership provisions in the Consolidation—Overall Subtopic (Subtopic 810-10) of the FASB Accounting Standards Codification, originally issued as FASB Statement No. 160, Noncontrolling Interests in Consolidated Financial Statements. Subtopic 810-10 establishes the accounting and reporting guidance for noncontrolling interests and changes in ownership interests of a subsidiary. An entity is required to deconsolidate a subsidiary when the entity ceases to have a controlling financial interest in the subsidiary. Upon deconsolidation of a subsidiary, an entity recognizes a gain or loss on the transaction and measures any retained investment in the subsidiary at fair value. The gain or loss includes any gain or loss associated with the difference between the fair value of the retained investment in the subsidiary and its carrying amount at the date the subsidiary is deconsolidated. In contrast, an entity is required to account for a decrease in ownership interest of a subsidiary that does not result in a change of control of the subsidiary as an equity transaction. ASU 2010-2 is effective for the Company starting January 1, 2010. The Company does not expect the adoption of ASU 2010-2 to have a material impact on the Company's results of operations or financial position.

The Company has implemented all new accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

NOTE 5 - RELATED PARTY TRANSACTIONS

As of December 31, 2010, the Company was indebted to its former CEO, Steve Bonenberger, in the amount of $103,670 for loans and $60,000 to Mr. Bonenberger for accrued compensation.



14






As of September 30, 2011, the Company is indebted to its former CEO, Steve Bonenberger, in the amount of $51,960 for loans to the company.

As of September 30, 2011 and December 31, 2010 the Company owes a former Director $39,369 and $31,593, respectively, for funds received to cover certain operating expenses.

 

On June 30, 2011 a Quit Claim Deed was executed transferring the property held for sale and the related liability to Steven Bonenberger, the Company’s former CEO, in connection with forgiveness of accrued salary of $60,000. The forgiveness of accrued salary was treated as additional paid in capital.



NOTE 6 – PROPERTY

Property and equipment consisted of the following at:


 

September 30, 2011

 

December 31, 2010

Building

     $                         -

 

 $            1,395,612

Office equipment

-

 

27,080

Total

-

 

1,422,692

Less: Accumulated depreciation

-

 

(193,861)

Property & equipment, net

      $                        -

 

$            1,228,831


On November 10, 2010, the Company received a “Notice of Default and Election to Sell Under Deed of Trust” from the trustee holding the mortgage secured by the building with a cost of $1,395,612.  The Company had a legal right to bring the account into good standing by paying all past due payments plus costs and expenses; however, was unable to do so.  On March 18, 2011 a “Trustee’s Deed Upon Sale” was finalized and the property was returned to the lien holder.


As of March 31, 2011 it was determined that all furniture and equipment was no longer being utilized and would be disposed of without sale. As such both the book value and the related accumulated depreciation were removed from the balance sheet.  There was no depreciation expense recorded in the current year to date.


NOTE 7 - PROPERTY HELD FOR RESALE

 

In April of 2009 the Company reacquired a residential property for sale and assumed the mortgage. The value of the property has been recorded at its appraised value which equals the amount of mortgage of $496,000 as the property is held for sale the Company is not depreciating the asset. On June 30, 2011 a Quit Claim Deed was executed transferring the property and related liability to Steven Bonenberger, the Company’s former CEO, in connection with forgiveness of accrued salary of $60,000.

 



15






NOTE 8 - NOTES PAYABLE

 

Notes payable at September 30, 2011 and December 31, 2010 are comprised of the following:


 

September 30,

2011

 

December 31,
2010

 

 

 

 

Note payable to lending institution, original balance of $980,000 interest at 7.5% per annum. Required monthly principal and interest payments of  $6,852 through 2034. Collateralized by the building. This agreement was modified in February 2009 to monthly payments of $4,100 all of which goes toward interest. This loan was in default as the Company was not meeting the obligation of $4,100 per month, causing the note to become a current obligation. Refer to Note 6.

$

-

 

$

890,998

 

 

 

 

Mortgage payable secured by a building, 7.875% interest only for ten years. Refer to Note 7.

-

 

496,000

 

 

 

 

Convertible note to investors, past due,  20% interest

50,000

 

54,800

 

 

 

 

 

 

Credit line from a bank up to $500,000, interest only at one percent over prime. This obligation was in default.

-

 

495,000

 

 

 

 

Note payable for $90,000, 10% interest. Accrued interest shall be due and payable annually on the anniversary date of the note and the entire principal balance of the note (together with all accrued and unpaid interest) shall be due and payable on December 31, 2013.

90,000

 

-

 

 

 

 

Loans from various investors, 10% interest

71,761

 

42,338

 

 

 

 

 

 

Total

211,761

 

1,979,136

 

 

Less long term portion

50,000

 

-

 

 

Short term note payable

$

161,761

 

$

1,979,136


In October 2010 the Company received an intent to accelerate the Company’s $495,000 credit line. This action accelerated the $495,000 balance becoming due in full. On November 16, 2010, Wells Fargo Bank filed a dismissal in connection with the intent to accelerate and has agreed to a loan modification. As of the date hereof the terms of the loan modification have been finalized. Two of The Company’s former officers were personal guarantees on this loan and have personally entered into a settlement agreement with Wells Fargo relieving the Company of any further debt obligation.


On November 10, 2010, the Company received a “Notice of Default and Election to Sell Under Deed of Trust” from the trustee holding the mortgage secured by the building with a cost of $1,395,612. The Company had a legal right to bring the account into good standing by paying all past due payments plus costs and expenses; however, was unable to do so.  On March 18, 2011 a “Trustee’s Deed Upon Sale” was finalized and the property was returned to the lien holder releasing the company of the related debt The total due on the mortgage including the remaining principal balance and accrued interest at March 18, 2011 was $897,418.  The company has recorded a loss of $331,413 as a result of the property foreclosure.





16




NOTE 9 – CONTINGENT LIABILITY

 

During the second quarter a settlement agreement with Wells Fargo Bank was finalized by a Stipulation for Entry of Judgment for the line of credit held by prior officers of the company. Two of The Company’s former officers were personal guarantees on this loan and have personally entered into the before mentioned settlement agreement with Wells Fargo. The Company believes that this settlement relieves it of any further debt obligation.


In the event that the former officers were to default on their obligation to repay the line of credit with Wells Fargo Bank there is a remote possibility that the Bank could look to the Company for recovery of any remaining monies due.


NOTE 10 - LEASES

Our corporate headquarters are located in Carson City, Nevada, whereby we lease space for approximately $100 a month


NOTE 11 - CONVERTIBLE NOTES AND DERIVATIVE LIABILITY


On April 19, 2010 The Company entered into a financing agreement with Granada Capital Consulting, Inc. Terms of the agreement consisted of up to a $100,000 convertible debenture loan to be used for working capital, of which $10,000 was to be paid upon closing of the agreement. The conversion price is 50% of the average of the three lowest trading prices during the twenty day period prior to conversion. As of March 31, 2011 only the initial $10,000 had been loaned to the company. On May 18, 2011, $5,000 of the outstanding balance was converted into 6,289 shares of common stock. The Company is accounting for the conversion option in the Convertible Note and the conversion price as a derivative liability in accordance with FASB ASC Topic regarding, “Accounting for Derivative Instruments and Hedging Activities” and FASB ASC Topic regarding “Accounting for Derivative Financial Instruments Indexed to and Potentially Settled in a Company’s Own Stock” due to the fact that the conversion feature has a variable conversion price.

The fair value of the Convertible Note was determined utilizing the Black-Scholes stock option valuation model. The significant assumptions used in the valuation are:  the exercise price as noted above; the stock price as of the measurable date; expected volatility of 301%; risk free interest rate of approximately 1.60%; and a term of three years. The resulting initial fair value and subsequent liability of any potential conversion was immaterial and therefore had no impact to the financial statements.

During the quarter ended June 30, 2011, the Company issued a $10,000 convertible note. The note was issued with interest at 20% per annum, due within six months. The fair value of the Convertible Note was determined utilizing the Black-Scholes stock option valuation model. The significant assumptions used in the valuation are:  the exercise price as noted above; the stock price as of the measurable date; expected volatility of 154%; risk free interest rate of approximately .19%; and a term of six months. The resulting initial fair value and subsequent liability of any potential conversion was immaterial and therefore had no impact to the financial statements.

During the quarter ended September 30, 2011, the Company issued a $60,000 discounted convertible promissory note for a purchase price of $30,000. The note was issued with no interest rate and is due within two years. As of September 30, 2011 the note was convertible into 600,000,000 shares of common stock and $3,288 of the $30,000 discount was amortized to interest expense.  A derivative liability of $38,896 was calculated using the Black Scholes pricing model using 1.75 years to maturity and assuming a risk free rate of 0.22% and a volatility of 146%. The derivative liability will be revalued at the end of each reporting period.


During the quarter ended September 30, 2011, the Company issued a $90,000 convertible promissory note with 10% interest. Accrued interest shall be due and payable annually on the anniversary date of the note and the entire principal balance of the note (together with all accrued and unpaid interest) shall be due and payable on December 31, 2013. As of September 30, 2011 the note was convertible into 1,800,000,000 shares of common stock.  A derivative liability of $61,285 was calculated using the Black Scholes pricing model using 2.25 years to maturity and assuming a risk free rate of 0.22% and a volatility of 133%. The derivative liability will be revalued at the end of each reporting period.



17





NOTE 12 – INCOME TAXES

A valuation allowance is required by ASC Topic 740, if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The need for the valuation allowance is evaluated periodically by management. Based on available evidence, management concluded that valuation allowances of 100 percent for September 30, 2011 and December 31, 2010 were necessary. Significant components of the Company's net September deferred tax assets are as follows:


 

 

 

September 30, 2011

 

 

December 31, 2010

 

Deferred tax assets:

 

 

 

 

 

 

 

 

NOL carryover

 

 $

(7,138,343) 

 

 

 $

(6,938,703) 

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

None

 

 

 

 

 

 

Valuation allowance

 

 

7,138,343

 

 

 

6,938,703

 

 

 

 

 

 

 

 

 

 

Net deferred tax asset

 

$

-

 

 

$

-

 


The valuation allowance increased by $199,640 during the nine months ended September 30, 2011.


A reconciliation of the statutory income tax rate and the effective income tax rate for the period ended September 30, 2011 and December 31, 2010 is as follows:

 

 

September 30,

2011

 

 

December 31,

2010

 

 

 

 

 

 

 

 

Statutory federal income tax rate

 

 

(0.34)%

 

 

 

(0.34)%

 

 Net operating loss

 

 

34 %

 

 

 

34%

 

 Effective income tax (benefit) rate

 

 

-

 

 

 

-

 



NOTE 13 – STOCKHOLDERS’ EQUITY

Preferred Stock


During the first quarter, the Company entered into a Series A Preferred Stock Purchase Agreement with Ginew Holdings, LLC, pursuant to which the Ginew Holdings, LLC purchased 355 shares of Series A Preferred Stock for cash totaling $60,000,  $30,000 of which was collected as of December 31, 2010 and had been recorded as a stock payable.  The Company believes the issuance of the shares is exempt from the registration and prospectus delivery requirement of the Securities Act of 1933 by virtue of Section 4(2).  







18




Common Stock

 

During the year ended December 31, 2010, the Company issued 3,989,500,000 shares of common stock and cancelled 542,000,000 shares for total debt reduction of $106,690. These shares were issued based upon the exemption from registration found in Section 4(2) of the Securities Act. In addition, during year ending December 31, 2010, the Company issued 385,000,000 shares for services valued at $38,500. These shares were issued under an S-8 registration statement.


During the fourth quarter of 2010, the Company received cash totaling $40,000 for shares to be issued of $80,000. As of September 30, 2011, 300,000,000 shares were issued reducing the payable by $30,000.


During the three months ended March 31, 2011, the Company issued 250,000,000 shares of common stock for cash received during the fourth quarter of 2010 and $3,850 during the current quarter for total proceeds of $29,573. The Company believes the issuance of the shares is exempt from the registration and prospectus delivery requirement of the Securities Act of 1933 by virtue of Section 4(2).


During the second quarter the Board of Directors approved the conversion of $5,000 of a $10,000 convertible note payable into 100,000,000 shares of common stock. As of September 30, 2011 the shares had not yet been issued and have been accounted for as a stock payable.


On August 2, 2011, the Company filed a Certificate of Change with the Nevada Secretary of State in order to effectuate a one for fifteen thousand nine hundred (1:15,900) reverse stock split (the “Reverse Split”) and a contemporaneous one for fifteen thousand nine hundred (1:15,900) reduction in the number of the Company’s authorized shares of common stock, par value $0.00001 (the "Common Stock"), in accordance with the procedure authorized by Nevada Revised Statutes (NRS) 78.207. The board of directors determined that it would be in the Company's best interest to affect the Reverse Split and approved this corporate action by unanimous written consent. The Reverse Split does not require shareholder approval. Approval for the reverse split is still pending.



NOTE 14 - DEBT FORGIVENESS


In June 2010 The Company entered into a settlement agreement with a holder of a convertible debt instrument in the amount of $1,011,443, whereby the borrowings were cancelled resulting in a gain on forgiveness of debt.  As the debt related to this derivative calculation was forgiven, the corresponding derivative was also adjusted to zero.

In addition, in 2010, accrued salary of $295,000 due to a former officer was also forgiven. The amount was treated as additional paid in capital.


In the first quarter of 2011 notes payable totaling $9,800 were forgiven by the debt holder resulting in a gain on forgiveness of debt.


On June 30, 2011 a Quit Claim Deed was executed transferring the property held for sale and the related liability to Steven Bonenberger, the Company’s former CEO, in connection with forgiveness of accrued salary of $60,000. The forgiveness of accrued salary was treated as additional paid in capital.


NOTE 15 – SIGNIFICANT EVENTS


On March 23, 2011, the Board of Directors and majority stockholders of the Company approved the entry into a Partial Purchase Agreement. Under the terms of the Agreement, Gate Technologies, LLC acquired sixty percent (60%) ownership of the operating division, Angels In Action, for total cash consideration of ninety thousand dollars ($90,000) and six hundred thousand dollars ($600,000) in the form of Gate Technologies, LLC Units contributed by Vince Molinari and Lori Livingston.  On September 28, 2011, the Company and Gate Technologies, entered into a Settlement Agreement whereby the parties agreed to rescind the Partial Purchase Agreement. On September 29, 2011 the parties executed a promissory note whereby the Company has agreed to pay to Gate Technologies $90,000 plus 10% interest. Interest is due annually and the entire note plus any unpaid interest is due on December 31, 2013.



19




 

On August 1, 2011, the Company filed Articles of Merger with the Secretary of State of Nevada in order to effectuate a merger whereby the Company (as Angel Acquisition Corp.) merged with its wholly-owned subsidiary, BioGeron, Inc., as a parent/ subsidiary merger with the Company as the surviving corporation. This merger, which became effective as of August 1, 2011, was completed pursuant to NRS 92A.180. Shareholder approval to this merger was not required under NRS 92A.180.  In process of the merger, the Company's name has been changed to "BioGeron, Inc." and the Company's Articles of Incorporation have been amended to reflect this name change


NOTE 16 - SUBSEQUENT EVENTS


The company has evaluated subsequent events in accordance with the provisions of ASC 855 noting no reportable subsequent events.





20






ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERAITONS

 

Forward-Looking Information

 

Much of the discussion in this Item is "forward looking" as that term is used in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934. Actual operations and results may materially differ from present plans and projections due to changes in economic conditions, new business opportunities, changed business conditions, and other developments. Other factors that could cause results to differ materially are described in our filings with the Securities and Exchange Commission.

 

There are several factors that could cause actual results or events to differ materially from those anticipated, and include, but are not limited to general economic, financial and business conditions, changes in and compliance with governmental laws and regulations, including various state and federal environmental regulations, our ability to obtain additional financing from outside investors and/or bank and mezzanine lenders and our ability to generate sufficient revenues to cover operating losses and position us to achieve positive cash flow. Readers are cautioned not to place undue reliance on the forward- looking statements contained herein, which speak only as of the date hereof. We believe the information contained in this Form 10-Q to be accurate as of the date hereof. Changes may occur after that date. We will not update that information except as required by law in the normal course of its public disclosure practices. Additionally, the following discussion regarding our financial condition and results of operations should be read in conjunction with the financial statements and related notes contained in Item 1 of Part I of this Form 10-Q, as well as the financial statements in Item 8 of Part II of our Form 10-K for the fiscal year ended, December 31, 2010.


Company Overview 

 

BioGeron, Inc. (the “Company”) a Nevada corporation, was incorporated on March 10, 1999. The Company was formerly Palomar Enterprises, Inc. On February 5, 2008, the Company changed its name to Angel Acquisition Corp. to properly reflect the change in business direction.


During the quarter ended September 30, 2010, the Company formed a wholly owned subsidiary, BioGeron, Inc. BioGeron is a privately  held  early  stage  bio-nutritional  supplement  designer,  manufacturer,  wholesaler  and  retailer.  It is a part of the Neutraceutica Industry.


On August 1, 2011, the Company filed Articles of Merger with the Secretary of State of Nevada in order to effectuate a merger whereby the Company (as Angel Acquisition Corp.) merged with its wholly-owned subsidiary, BioGeron, Inc., as a parent/ subsidiary merger with the Company as the surviving corporation. This merger, which became effective as of August 1, 2011, was completed pursuant to NRS 92A.180. Shareholder approval to this merger was not required under NRS 92A.180.  In process of the merger, the Company's name has been changed to "BioGeron, Inc." and the Company's Articles of Incorporation have been amended to reflect this name change


DEPARTURE AND APPOINTMENT OF DIRECTORS AND PRINCIPAL OFFICERS


On November 1, 2010, the Company accepted the resignation of Lew Graham as President of the Company.  Mr. Graham continued to serve as Chief Operating Officer and a member of the Board of Directors.   Effective as of the same date, to fill the vacancy created by Mr. Graham’s resignation, the Board of Directors appointed Milton C. Ault, III as President.


On January 10, 2011, the Company accepted the resignation of Steve Bonenberger as Chairman of the Board of Directors of the Company.  Mr. Bonenberger continued to serve as Chief Executive Officer, Chief Financial Officer, Secretary and a member of the Board of Directors. Effective as of the same date, to fill the vacancy created by Mr. Bonenberger’s resignation, the Board of Directors appointed Vincent Molinari as Chairman of the Board of Directors.



21





On January 10, 2011, the Company accepted the resignations of Michael Edwards and Lew Graham from the Board of Directors. Effective as of the same date, the Board of Directors appointed Lori Livingston as a member of the Board of Directors.


On January 10, 2011, the Company accepted the resignation of Milton C. Ault, III as President. Effective on the same date to fill the vacancy created by Mr. Ault’s resignation, the Company appointed Steve Bonenberger as President.


On January 10, 2011, the Company accepted the resignation of Lew Graham as Chief Operating Officer. At this time, no one has been chosen to fill the vacancy of Chief Operating Officer left by the resignation of Mr. Graham.


On May 27, 2011, the Company accepted the resignation of Vincent Molinari as a Chairman of the Board of Directors and Lori Livingston as a member of the Board of Directors.  


On June 22, 2011, the Company accepted the resignations of Steven Bonenberger as Chief Executive Officer, President, Secretary and Chief Financial Officer of the Company.  Effective on the same date the Company appointed Michael Edwards as Chief Executive Officer, President, Secretary, Chief Financial Officer and member of the Board of Directors.


On June 23, 2011, the Company accepted the resignation of Steven Bonenberger as a member of the Board of Directors of the Company.


As of the date hereof, Michael Edwards serves as the Company’s sole officer and director.


CURRENT BUSINESS PLAN


BioGeron Inc. operations are part of the Nutraceutical Industry, which in 2009, had sales in excess of $108 Billion according to the Nutrition Business Journal.  The BioGeron product theme is “Nature and Science to Enhance and Extend Life”.   The company is positioned to create and manufacture a new generation of nutraceutical products to both the retail and wholesale markets worldwide.  For the past year, BioGeron has focused it's energy and resources on the bio-nutraceutical marketplace with the specific goal of offering products that may improve the health of consumers.  The company standard is to provide premiere nutraceutical products using premiere ingredients and produced and packaged to the highest standards in the industry, at FDA inspected facilities that are FDA-GMP certified and compliant.


The Omega 3 Plus products are the first to be released and the initial distribution period has shown great progress.  The company has determined a number of new formulas and supplements they plan to add to their product line and scheduled to be released before year end.   Other products will be announced soon as they are ready for sale and distribution on a wholesale and retail basis.


It is also expected that the tentative agreement for the acquisition of a unique Congnitive-Memory formula, aimed at the growing Alzheimers and memory-impaired population worldwide, will be finalized by the end of the year.  The company is extremely excited about this product.

 

For more information about BioGeron, Inc. and its products, please visit the company’s website at www.BioGeronInc.com.





22






As of September 30, 2011, the Company operated Angels in Action, a micro lending division:

[biogeronform10q9302011fin001.jpg]

Angels in Action is committed to changing the direction of our nation’s local economies, one business at a time. We have built an online Microfinance community where entrepreneurs and patrons come together to form virtual business incubators. Our mission is to ensure that the entrepreneurial spirit on which our country was founded is able to flourish in the communities in which we live and work.

http://www.angelsinaction.tv

On March 23, 2011, the Board of Directors and majority stockholders of the Company approved the entry into a Partial Purchase Agreement. Under the terms of the Agreement, Gate Technologies, LLC acquired sixty percent (60%) ownership of the operating division, Angels In Action for total cash consideration of ninety thousand dollars ($90,000) and six hundred thousand dollars in the form of Gate Technologies, LLC Units contributed by Vince Molinari and Lori Livingston. On September 28, 2011, the Company and Gate Technologies, entered into a Settlement Agreement whereby the parties agreed to rescind the Partial Purchase Agreement. On September 29, 2011 the parties executed a promissory note whereby the Company has agreed to pay to Gate Technologies $90,000 plus 10% interest. Interest is due annually and the entire note plus any unpaid interest is due on December 31, 2013.

On July 5, 2011, the Company’s operating division The Palomar Group ceased operations in connection with the Company’s change in business direction within the nutraceutical industry.  


KEY PERSONNEL

 

Our future financial success depends to a large degree upon the effort of Mr. Edwards, Chief Executive Officer, Chief Financial Officer and member of the Board of Directors as the date hereof. Mr. Edwards has played a major role in developing and executing our business strategy. The loss of Mr. Edwards could have an adverse effect on our business and our chances for profitable operations. While we intend to employ additional management and marketing personnel in order to minimize the critical dependency upon any one person, there can be no assurance that we will be successful in attracting and retaining the persons needed. If we do not succeed in retaining and motivating our current employees and attracting new high quality independent agents, our business could be adversely affected.


We do not maintain key man life insurance on the life of Mr. Edwards.


OUR FINANCIAL RESULTS MAY BE AFFECTED BY FACTORS OUTSIDE OF OUR CONTROL

 

Our future operating results may vary significantly from quarter to quarter due to a variety of factors, many of which are outside our control. Our anticipated expense levels are based, in part, on our estimates of future revenues and may vary from our projections. We may be unable to adjust spending rapidly enough to compensate for any unexpected revenues shortfall. Accordingly, any significant shortfall in revenues in relation to our planned expenditures would materially adversely affect our business, operating results, and financial condition.


We cannot predict with certainty our revenues and operating results. Further, we believe that period-to-period comparisons of our operating results are not necessarily a meaningful indication of future performance.




23





EMPLOYEES

 

We have one full-time employee and two independent agents working for the Company as of September 30, 2011. As we grow, we will need to attract an unknown number of additional qualified employees and independent agents. Although we have experienced no work stoppages and believe our relationships with our employees are good, we could be unsuccessful in attracting and retaining the persons needed. None of our employees are currently represented by a labor union. We expect to have a ready source of available labor to support our growth.


Management's Plan of Operations


Three Months Ended September 30, 2011 compared to the Three Months Ended September 30, 2010.


Results of Operations

 

Revenue


Total revenue was $2,000 for the three months ended September 30, 2011 compared to $23,976 for the prior period. The decrease in revenue is a result of economic factors in the real estate industry as well as the Company beginning to concentrate on its new business plan.

   

Total operating expenses for the three months ended September 30, 2011 compared to 2010 increased to $46,226 from $43,235 in the prior period. The majority of this increase was in general and administrative expenses.


The net loss for the three months ended September 30, 2011 was $156,876 compared to a net loss of $49,979 for the three months ended September 30, 2010. The increase in net loss is mainly attributed to a loss on derivative liability of $101,181.



Nine Months Ended September 30, 2011 compared to the Nine Months Ended September 30, 2010.


Results of Operations

 

Revenue


Total revenue was $26,355 for the nine months ended September 30, 2011 compared to $100,284 for the prior period.  

 

Total operating expenses for the nine months ended September 30, 2011 compared to 2010 decreased to $142,843 from $187,065 in the prior period.


The net loss for the nine months ended September 30, 2011 was $587,175 compared to a net gain of $1,262,579 for the nine months ended September 30, 2010. The net gain was attributed to a recorded forgiveness of debt of $1,579,394 resulting from foreclosure of property. In 2011, in addition to operating expenses, the net loss also consisted of a loss on derivative liability of $100,181 and a loss on disposal of an asset of $331,413.



Liquidity and Capital Resources

 

As of September 30, 2011, we had a deficiency in working capital of $314,223.




24




 

Critical Accounting Policies

 

The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and judgments that affect our reported assets, liabilities, revenues, and expenses, and the disclosure of contingent assets and liabilities. We base our estimates and judgments on historical experience and on various other assumptions we believe to be reasonable under the circumstances. Future events, however, may differ markedly from our current expectations and assumptions. While there are a number of significant accounting policies affecting our consolidated financial statements, we believe the following critical accounting policy involve the most complex, difficult and subjective estimates and judgments.

 

 

Recent Accounting Pronouncements


In March 2010, the FASB (Financial Accounting Standards Board) issued Accounting Standards Update 2010-11 (ASU 2010-11), “Derivatives and Hedging (Topic 815): Scope Exception Related to Embedded Credit Derivatives.”  The amendments in this Update are effective for each reporting entity at the beginning of its first fiscal quarter beginning after June 15, 2010.  Early adoption is permitted at the beginning of each entity’s first fiscal quarter beginning after issuance of this Update.  The Company does not expect the provisions of ASU 2010-11 to have a material effect on the financial position, results of operations or cash flows of the Company.


In February 2010, the FASB Accounting Standards Update 2010-10 (ASU 2010-10), “Consolidation (Topic 810): Amendments for Certain Investment Funds.”  The amendments in this Update are effective as of the beginning of a reporting entity’s first annual period that begins after November 15, 2009 and for interim periods within that first reporting period. Early application is not permitted.  The Company’s adoption of provisions of ASU 2010-10 did not have a material effect on the financial position, results of operations or cash flows.


In February 2010, the FASB issued ASU No. 2010-09 “Subsequent Events (ASC Topic 855) “Amendments to Certain Recognition and Disclosure Requirements” (“ASU No. 2010-09”). ASU No. 2010-09 requires an entity that is an SEC filer to evaluate subsequent events through the date that the financial statements are issued and removes the requirement for an SEC filer to disclose a date, in both issued and revised financial statements, through which the filer had evaluated subsequent events. The adoption did not have an impact on the Company’s financial position and results of operations.


In January 2010, the FASB issued an amendment to ASC 820, Fair Value Measurements and Disclosure, to require reporting entities to separately disclose the amounts and business rationale for significant transfers in and out of Level 1 and Level 2 fair value measurements and separately present information regarding purchase, sale, issuance, and settlement of Level 3 fair value measures on a gross basis.  This standard, for which the Company is currently assessing the impact, is effective for interim and annual reporting periods beginning after December 15, 2009 with the exception of disclosures regarding the purchase, sale, issuance, and settlement of Level 3 fair value measures which are effective for fiscal years beginning after December 15, 2010.


In January 2010, the FASB issued an amendment to ASC 505, Equity, where entities that declare dividends to shareholders that may be paid in cash or shares at the election of the shareholders are considered to be a share issuance that is reflected prospectively in EPS, and is not accounted for as a stock dividend.  This standard is effective for interim and annual periods ending on or after December 15, 2009 and is to be applied on a retrospective basis.  The adoption of this standard is not expected to have a significant impact on the Company’s financial statements.  





25






The Company has implemented all new accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES OF MARKET RISK


We Will Need to Raise Additional Capital to Finance Operations


Our operations have relied almost entirely on external financing to fund our operations.  Such financing has historically come from a combination of borrowings and from the sale of common stock and assets to third parties.  We will need to raise additional capital to fund our anticipated operating expenses and future expansion.  Among other things, external financing will be required to cover our operating costs.  We cannot assure you that financing whether from external sources or related parties will be available if needed or on favorable terms.  The sale of our common stock to raise capital may cause dilution to our existing shareholders.  Our inability to obtain adequate financing will result in the need to curtail business operations.  Any of these events would be materially harmful to our business and may result in a lower stock price.


There is Substantial Doubt About Our Ability to Continue as a Going Concern Due to Recurring Losses and Working Capital Shortages, Which Means that We May Not Be Able to Continue Operations Unless We Obtain Additional Funding


The report of our independent accountants on our December 31, 2010 financial statements includes an explanatory paragraph indicating that there is substantial doubt about our ability to continue as a going concern due to recurring losses and working capital shortages.  Our ability to continue as a going concern will be determined by our ability to obtain additional funding.  Our financial statements do not include any adjustments that might result from the outcome of this uncertainty.


Our Common Stock May Be Affected By Limited Trading Volume and May Fluctuate Significantly


There has been a limited public market for our common stock and there can be no assurance that an active trading market for our common stock will develop.  As a result, this could adversely affect our shareholders' ability to sell our common stock in short time periods, or possibly at all.  Our common stock has experienced, and is likely to experience in the future, significant price and volume fluctuations that could adversely affect the market price of our common stock without regard to our operating performance.  In addition, we believe that factors such as quarterly fluctuations in our financial results and changes in the overall economy or the condition of the financial markets could cause the price of our common stock to fluctuate substantially. Substantial fluctuations in our stock price could significantly reduce the price of our stock.

 There is no Assurance of Continued Public Trading Market and Being a Low Priced Security may Affect the Market Value of Our Stock

 

To date, there has been only a limited public market for our common stock. Our common stock is currently quoted on the OTCBB. As a result, an investor may find it difficult to dispose of, or to obtain accurate quotations as to the market value of our stock. Our stock is subject to the low-priced security or so called "penny stock" rules that impose additional sales practice requirements on broker-dealers who sell such securities. The Securities Enforcement and Penny Stock Reform Act of 1990 requires additional disclosure in connection with any trades involving a stock defined as a penny stock (generally, according to recent regulations adopted by the SEC, any equity security that has a market price of less than $5.00 per share, subject to certain exceptions that we no longer meet). For example, brokers/dealers selling such securities must, prior to effecting the transaction, provide their customers with a document that discloses the risks of investing in such securities. Included in this document are the following:



26




 

- the bid and offer price quotes in and for the "penny stock," and the number of shares to which the quoted prices apply,

 

- the brokerage firm's compensation for the trade, and

 

- the compensation received by the brokerage firm's sales person for the trade.

 

In addition, the brokerage firm must send the investor:

 

- a monthly account statement that gives an estimate of the value of each "penny stock" in the investor's account, and

 

- a written statement of the investor's financial situation and investment goals.

 

If the person purchasing the securities is someone other than an accredited investor or an established customer of the broker/dealer, the broker/dealer must also approve the potential customer's account by obtaining information concerning the customer's financial situation, investment experience and investment objectives. The broker/dealer must also make a determination whether the transaction is suitable for the customer and whether the customer has sufficient knowledge and experience in financial matters to be reasonably expected to be capable of evaluating the risk of transactions in such securities. Accordingly, the Commission's rules may limit the number of potential purchasers of the shares of our common stock.

 

Resale restrictions on transferring "penny stocks" are sometimes imposed by some states, which may make transaction in our stock more difficult and may reduce the value of the investment. Various state securities laws pose restrictions on transferring "penny stocks" and as a result, investors in our common stock may have the ability to sell their shares of our common stock impaired.

 

There can be no assurance we will have market makers in our stock. If the number of market makers in our stock should decline, the liquidity of our common stock could be impaired, not only in the number of shares of common stock which could be bought and sold, but also through possible delays in the timing of transactions, and lower prices for the common stock than might otherwise prevail. Furthermore, the lack of market makers could result in persons being unable to buy or sell shares of the common stock on any secondary market.

 

We Could Fail to Retain or Attract Key Personnel


Our future success depends in significant part on the continued services of Michael Edwards, our Chief Executive Officer.  We cannot assure you we would be able to find an appropriate replacement for key personnel.  Any loss or interruption of our key personnel's services could adversely affect our ability to develop our business plan.  We do not have life insurance on Mr. Edwards.


Nevada Law and Our Charter May Inhibit a Takeover of Our Company That Stockholders May Consider Favorable


Provisions of Nevada law, such as its business combination statute, may have the effect of delaying, deferring or preventing a change in control of our company.  As a result, these provisions could limit the price some investors might be willing to pay in the future for shares of our common stock.



27




 

ITEM 4. CONTROLS AND PROCEDURES


Evaluation of Disclosure Controls and Procedures


We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are designed to be effective in providing reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (the “SEC”), and that such information is accumulated and communicated to our management to allow timely decisions regarding required disclosure.

 

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. The design of any system of controls is based, in part, upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.


As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of management, including our chief executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, management concluded that our disclosure controls and procedures are effective as of September 30, 2011 to cause the information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods prescribed by SEC, and that such information is accumulated and communicated to management, including our chief executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.


PART II - OTHER INFORMATION


ITEM 1. LEGAL PROCEEDINGS.


On November 10, 2010, the Company received a “Notice of Default and Election to Sell Under Deed of Trust” from the trustee holding the mortgage secured by the building with a cost of $1,395,612.  The Company had a legal right to bring the account into good standing by paying all past due payments plus costs and expenses; however, was unable to do so.  On March 18, 2011 a “Trustee’s Deed Upon Sale” was finalized and the property was returned to the lien holder.


ITEM 1A. RISK FACTORS


Not applicable.


ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.


During the three months ended March 31, 2011, the Company issued 250,000,000 shares of common stock for cash received during the fourth quarter of 2010 totaling $25,723. The Company believes the issuance of the shares is exempt from the registration and prospectus delivery requirement of the Securities Act of 1933 by virtue of Section 4(2).



28




 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES


None.


ITEM 4. (REMOVED AND RESERVED)


None.


ITEM 5. OTHER INFORMATION


None.

 

ITEM 6. EXHIBITS


Exhibit No.

 

 Identification of Exhibit

 

 

 

3.1**

 

Articles of Incorporation

3.2**

 

Articles of Amendment to Articles of Incorporation

3.3**

 

Articles of Amendment to Articles of Incorporation

3.4**

 

Certificate of Change

3.5**

 

Certificate of Correction to the Certificate of Change

3.6**

 

Certificate of Designation for the Series A Preferred Stock

3.7**

 

Certificate of Designation for the Series B Preferred Stock

3.8**

 

Certificate of Designation for the Series C Preferred Stock

3.9**

 

Articles of Amendment to Articles of Incorporation

3.10 **

 

Articles of Amendment to Articles of Incorporation

3.11**

 

Bylaws

3.12**

 

Amendment to Certificate of Designation for the Series B Preferred Stock

3.13**

 

Certificate of Change

3.14**

 

Articles of Merger

14**

 

Code of Ethics

21**

 

Subsidiaries

31*

 

Certification of Chief Executive Officer and Chief Executive pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32*

 

Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101*

 

Interactive Data Files for the BioGeron, Inc. Form 10Q for the period ended September 30, 2011

 

BioGeron, Inc.

 

 

 

Dated: November 14, 2011

By:

/s/  Michael Edwards  

 

 

Michael Edwards

 

 

Chief Executive Officer and Chief Financial Officer (Principal Accounting, Executive and Financial Officer)